ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,153Medicare Part D Prescriptions Filled, Including Refills
$692K Total Retail Price of All Prescriptions
800 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 654 582 S3
OMEPRAZOLE 548 508
SIMVASTATIN 524 487
LISINOPRIL 434 406
LOSARTAN POTASSIUM 386 380
LEVOTHYROXINE SODIUM 368 351
FUROSEMIDE 301 273
TRAZODONE HCL 291 265
AMLODIPINE BESYLATE 265 257
CITALOPRAM HBR 254 250
GABAPENTIN 239 210
CARVEDILOL 205 194
ZOLPIDEM TARTRATE 199 178
DONEPEZIL HCL 194 181
HYDROCHLOROTHIAZIDE 174 160
ALENDRONATE SODIUM 170 167
WARFARIN SODIUM 165 159
SERTRALINE HCL 159 131
METFORMIN HCL 150 144
TRAMADOL HCL 139 130
POTASSIUM CHLORIDE 131 112
FENOFIBRATE 127 111
METOPROLOL TARTRATE 124 120
CYMBALTA 113 100
KLOR-CON M20 112 110
GLIMEPIRIDE 109 101
AZITHROMYCIN 108 97
LANTUS 105 105
NAMENDA 104 104
ADVAIR DISKUS 102 93
BACLOFEN 90 57
ATORVASTATIN CALCIUM 89 80
QUETIAPINE FUMARATE 83 72
MIRTAZAPINE 82 82
FLUTICASONE PROPIONATE 81 68
METHYLPHENIDATE HCL 79 79
COMBIVENT 74 53
ATENOLOL 73 73
CLOPIDOGREL 70 69
METOPROLOL SUCCINATE 69 68
CIPROFLOXACIN HCL 66 58
PREDNISONE 62 60
SPIRONOLACTONE 62 48
FLUOXETINE HCL 58 55
OXYCODONE-ACETAMINOPHEN 56 55 S2
KLOR-CON 10 55 48
HYDRALAZINE HCL 53 53
OLANZAPINE 53 53
DIGOXIN 52 52
ALLOPURINOL 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.